Harald Peeters - Dept Gastroenterol, AZ St Lucas

基本信息

浏览量：31

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 120 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Low Remission Recapture after Ustekinumab Dose Optimization in Crohn's Disease: Results of the Randomized Placebo-Controlled Double-Blind REScUE Study

P. Bossuyt,J. F. Rahier,F. Baert,E. Louis,E. Macken,T. Lobaton, J. Busschaert,H. Peeters,P. Dewint,D. Franchimont,J. Dutre,B. Willandt, C. Claessens,O. Dewit,M. Ferrante,S. Vermeire

JOURNAL OF CROHNS & COLITIS (2025): i69-i70

引用0浏览0引用

Real-life Histological Remission in Ulcerative Colitis Patients Treated with Ustekinumab: Results from the Belgian SULTAN Trial

T. Holvoet,M. Truyens,C. Reenaers,F. Baert,S. Vandenbranden, C. Anneline,L. Pouillon,P. Dewint,W. Van Moerkercke,J. F. Rahier,L. Vandermeulen,J. Van Dongen,H. Peeters,G. Lambrecht,A. Vijverman,A. Hoorens, A. Vanhaecke,T. Lobaton

JOURNAL OF CROHNS & COLITIS (2025): i2075-i2075

引用0浏览0引用

Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study

Pauline Lemmens,Edouard Louis,Wouter Van Moerkercke,Lieven Pouillon,Michael Somers,Harald Peeters,Stijn Vanden Branden, Julie Busschaert,Filip Baert,Anneline Cremer,Philippe Potvin,Sophie Dewit,Arnaud Colard, Jo Swinnen,Guy Lambrecht,Christophe Claessens,Barbara Willandt,Pieter Dewint,Evi Van Dyck,Joao Sabino,Severine Vermeire,Marc Ferrante

CLINICAL GASTROENTEROLOGY AND HEPATOLOGYno. 1 (2024)

引用1浏览0WOS引用

Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study

Tom Holvoet,Marie Truyens,Cara De Galan,Harald Peeters,Francisco Mesonero Gismero,Ainara Elorza,Paola Torres,Liv Vandermeulen,Aranzazu Jauregui-Amezaga,Rocio Ferreiro-Iglesias,Yamile Zabana,Laia Peries Reverter,Jeroen Geldof,Triana Lobaton

JOURNAL OF CLINICAL MEDICINEno. 2 (2024)

引用1浏览0WOS引用

P576 Endoscopic Healing with Vedolizumab in Crohn's Disease Occurs Predominantly in the First 6 Months and is Independent of Serum Concentrations: Data from LOVE-CD

G. D'Haens,P. Bossuyt,F. Baert,T. Molnar,E. Clasquin,M. Lowenberg, N. Montazeri,H. Peeters,G. Lambrecht,S. Vermeire

JOURNAL OF CROHNS & COLITIS (2023): 704-705

引用0浏览0引用

Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes

Severine Vermeire,Jurij Hanzel,Mark Lowenberg,Marc Ferrante,Peter Bossuyt,Frank Hoentjen,Denis Franchimont,Karoly Palatka,Harald Peeters,Aart Mookhoek,Gert de Hertogh,Tamas Molnar,Wouter van Moerkercke,Triana Lobaton,Esme Clasquin,Melanie S. Hulshoff,Filip Baert,Geert D'Haens

Journal of Crohn s and Colitisno. 4 (2023): 540-547

引用0浏览0WOS引用

P495 Vedolizumab Trough Concentrations and Histological Remission in Ulcerative Colitis: Results from the LOVE-UC Study

J. Hanzel,F. Baert,M. Lowenberg,M. Ferrante,P. Bossuyt,F. Hoentjen,D. Franchimont,K. Palatka,H. Peeters,A. Mookhoek,G. de Hertogh,E. Clasquin,S. Vermeire,G. D'Haens

JOURNAL OF CROHNS & COLITIS（2023）

引用0浏览0引用

P782 Ustekinumab in Ulcerative Colitis: a Real-Life Effectiveness Study Across Multiple Belgian Centers (SULTAN)

T. Holvoet,M. Truyens,C. Reenaers,F. Baert,S. Vandenbranden,A. Cremer,L. Pouillon,P. Dewint,W. Van Moerkercke,J. F. Rahier,L. Vandermeulen,J. Van Dongen,H. Peeters,G. Lambrecht,A. Vijverman,T. Lobaton

Journal of Crohn s and Colitisno. Supplement_1 (2023): i916-i917

引用0浏览0引用

Role of Integrin Expression in the Prediction of Response to Vedolizumab: A Prospective Real‐life Multicentre Cohort Study

Cara De Galan,Gerard Bryan Gonzales,Sophie Van Welden,Simon Jan Tavernier,Triana Lobaton,Wouter Van Moerkercke,Beatrijs Strubbe,Harald Peeters,Elisabeth Macken,Martine De Vos,Debby Laukens,Pieter Hindryckx

Clinical and translational medicineno. 4 (2022)

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn